Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Complementary & Alternative Medicine
China's SFDA approves three new botanical drug products
January 5th, 2006
Global Pharmatech, Inc., (GBLP) announced that its majority-owned subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food & Drug Administration (SFDA) of the People's Republic of China. The approvals allow for its botanical drugs products, Jin Lian Hua Capsule, Gong Yan Kang Granules, and Wei Kang Ling Capsule, to be marketed and sold in China. Global Pharmatech, develops, manufactures, and markets proprietary drugs and nutritional supplements that are based on modernized Chinese medicine and biopharmacy. Through its subsidiaries, Global Pharmatech combines R&D of botanical drug products,...
Source: Women's Health Weekly (2006-01-05)
|
